Table 1 Baseline information by patient group (health optimisation and non-health optimisation)
From: Evaluating a pre-surgical health optimisation programme: a feasibility study
Non-health optimisation pathway | Health optimisation pathway | |||||||
|---|---|---|---|---|---|---|---|---|
Accepted referral to Healthy Lifestyles Service | Did not accept referral to Healthy Lifestyles Service | All health optimisation patients (accepted referral & did not accept referral combined) | ||||||
(n=318) | (n=51) | (n=133) | (n=184) | |||||
Sex: | ||||||||
Female | 195 | 61.3% | 36 | 70.6% | 79 | 59.4% | 115 | 62.5% |
Male | 123 | 38.7% | 15 | 29.4% | 54 | 40.6% | 69 | 37.5% |
Age (years): | ||||||||
Median, IQR | 72 | (66, 79) | 67 | (58, 74) | 70 | (63, 75) | 70 | (62, 75) |
Deprivation quintile: | ||||||||
1 (most deprived) | 10 | 3.1% | 3 | 5.9% | 11 | 8.3% | 14 | 7.6% |
2 | 23 | 7.2% | 10 | 19.6% | 8 | 6.0% | 18 | 9.8% |
3 | 34 | 10.7% | 8 | 15.7% | 29 | 21.8% | 37 | 20.1% |
4 | 120 | 37.7% | 20 | 39.2% | 42 | 31.6% | 62 | 33.7% |
5 (least deprived) | 131 | 41.2% | 10 | 19.6% | 43 | 32.3% | 53 | 28.8% |
Referral reason: | ||||||||
Hip | 133 | 41.8% | 15 | 29.4% | 34 | 25.6% | 49 | 26.6% |
Knee | 185 | 58.2% | 36 | 70.6% | 99 | 74.4% | 135 | 73.4% |
Smoking status: | ||||||||
Smoker | 5 | 1.6% | 8 | 15.7% | 12 | 9.0% | 20 | 10.9% |
Non-smoker | 297 | 93.4% | 41 | 80.4% | 118 | 88.7% | 159 | 86.4% |
Missing | 16 | 5.0% | 2 | 3.9% | 3 | 2.3% | 5 | 2.7% |
BMI (kg/m2): | ||||||||
< 18: underweight | 1 | 0.3% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
18–24: healthy weight | 99 | 31.1% | 1 | 2.0% | 3 | 2.3% | 4 | 2.2% |
25–29: overweight | 192 | 60.4% | 0 | 0.0% | 11 | 8.3% | 11 | 6.0% |
30+: obese | 9 | 2.8% | 50 | 98.0% | 117 | 88.0% | 167 | 90.8% |
Missing | 17 | 5.3% | 0 | 0.0% | 2 | 1.5% | 2 | 1.1% |
Median, IQR a | 26.0 | (24.0, 28.0) | 35.0 | (32.0, 38.2) | 33.0 | (31.0, 35.6) | 33.2 | (31.4, 36.3) |
Oxford score: | ||||||||
0–19: severe | 158 | 49.7% | 37 | 72.5% | 80 | 60.2% | 117 | 63.6% |
20–29: moderate | 149 | 46.9% | 13 | 25.5% | 50 | 37.6% | 63 | 34.2% |
30–39: mild | 6 | 1.9% | 0 | 0.0% | 2 | 1.5% | 2 | 1.1% |
40–48: normal | 0 | 0.0% | 0 | 0.0% | 1 | 0.8% | 1 | 0.5% |
Missing | 5 | 1.6% | 1 | 2.0% | 0 | 0.0% | 1 | 0.5% |
Median, IQR * | 19 | (15, 24) | 14 | (11, 20) | 17 | (12, 22) | 16 | (12, 21) |